SCHEMBL5151105

SCHEMBL5151105

Cc1cccc2c(C[C@@H](N)CO)c[nH]c12

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS2 Q07890 1/20 0.71
HTR2A P28223 3/20 0.57
SCN9A Q15858 2/20 0.57
MAPT P10636 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
NR3C1 P04150 2/20 0.47
PCSK9 Q8NBP7 1/20 0.47
PGR P06401 1/20 0.45
NR3C2 P08235 1/20 0.45
BRPF1 P55201 1/20 0.44
TRIM24 O15164 1/20 0.42
TRIM33 Q9UPN9 1/20 0.42
NR4A2 P43354 1/20 0.41
ADRB1 P08588 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
SLC6A2 P23975 1/20 0.41
HTR1D P28221 1/20 0.41
HTR1B P28222 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18509418 1.00 SOS2 (0.71) SOS2HTR2ASCN9AMAPTSMN1; SMN2
SCHEMBL5151098 1.00 SOS2 (0.71) SOS2HTR2ASCN9AMAPTSMN1; SMN2
SCHEMBL26617451 0.87 SOS2 (0.73) SOS2HTR2ASCN9AMAPTSMN1; SMN2
SCHEMBL10646800 0.83 SOS2 (1.00) SOS2HTR2AMAPTSMN1; SMN2NPSR1
SCHEMBL10182315 0.83 SOS2 (1.00) SOS2HTR2AMAPTSMN1; SMN2NPSR1
SCHEMBL10183456 0.83 SOS2 (1.00) SOS2HTR2AMAPTSMN1; SMN2NPSR1
SCHEMBL18156572 0.82 HTR2A (0.57) SOS2HTR2ASCN9APCSK9NR4A2
SCHEMBL10023253 0.80 SOS2 (0.68) SOS2HTR2AMAPTSMN1; SMN2NPSR1
SCHEMBL18509675 0.80 SCN9A (0.80) SOS2HTR2ASCN9AMAPTADRB1
SCHEMBL2033276 0.80 SOS2 (0.68) SOS2HTR2AMAPTSMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R SOS2 4597/4885HTR2A 11/4885SCN9A 3913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.